Harry Rein

Harry brings extensive experience from the venture capital sector. Most recently, he served as General Partner at Foundation Medical Partners, having been instrumental in its formation. Prior to Foundation, Harry served as Founder and Managing Partner at Canaan Partners. Prior to Canaan, Harry was President and CEO of GE Venture Capital Corporation. Harry currently serves on the Board of DeliverCareRX and served on the Board of Anadigics until 2016. He has served on the Board of over 20 public and private entrepreneurial companies, including: Cell Pathways; OraPharma (acquired by Johnson & Johnson); National MD (acquired by GE); OmniSonics; GenVec; CardioNet; and Spine Wave, and was an investor in Praecis Pharmaceuticals.